Cipla informs about board meeting

Cipla Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 500087 | NSE: CIPLA

19 Apr 2022 Evaluate

Cipla has informed that a meeting of the Board of Directors of the Company will be held on Tuesday, 10th May 2022 to consider and approve the audited standalone and consolidated financial results for the quarter and year ended 31st March 2022 and recommendation of dividend, if any. In compliance with the provision of the Company's Code of Conduct for Prevention of Insider Trading, the ‘Trading Window' for dealing in the securities of the Company has been closed from Friday, 1st April, 2022 up to Thursday, 12th May, 2022.

The above information is a part of company’s filings submitted to BSE.

Peers

Company Name	CMP
Sun Pharma. Inds.	1840.00
Dr. Reddys Labs.	1222.50
Cipla	1388.90
Lupin	2061.85
Zydus Lifesciences	1212.00
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.